Table 1.
Composition of different liposomal formulations: molar ratios of the building blocks and targeting sequences
Liposome type | Cholesterol | POPC | DMPE-DTPA | DSPE-PEG(2000) | RGD | Substance P |
---|---|---|---|---|---|---|
RLP | 2 | 3 | 0.3 | 0.3 | 0.3 (6 mol%) | |
SP-LP | 2 | 3 | 0.3 | 0.3 | 0.3 (6 mol%) | |
Hybrid-LP | 2 | 3 | 0.3 | 0.3 | 0.015 (0.3 mol%) | 0.015 (0.3 mol%) |
NoTarget-LP | 2 | 3 | 0.3 | 0.3 | – | – |
Abbreviations: DMPE, 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine; DSPE, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; DTPA, diethylenetriaminepentaacetic acid; Hybrid-LP, liposomal nanoparticle carrying an RGD and SP building block; LP, liposome; NoTarget-LP, liposomal nanoparticle with no targeting sequence; PEG, polyethylene glycol; POPC, 1-palmitoyl-sn-glycero-3-phosphocholine; RGD, arginine-glycine-aspartic acid; RLP, liposomal nanoparticle carrying an RGD building block; SP, substance P; SP-LP, liposomal nanoparticle carrying an SP building block.